Overview

A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of blinded, single ascending oral doses of ABT 072 under non-fasting conditions in healthy adult Japanese male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
Collaborator:
Abbott Japan Co.,Ltd